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Abstract
Background: The majority of small supernumerary marker chromosome cases arise de novo and their frequency in
newborns is 0.04%. We report on a girl with developmental delay and dysmorphic features with a non-mosaic de
novo sSMC that originated from the pericentric region of q arm in chromosome 17.
Case presentation: The girl presented with developmental delay, speech delay, myopia, mild muscle hypotonia,
hypoplasia of orbicular muscle, poor concentration, and hyperactivity. Main dysmorphic features included: round face,
microstomia, small chin, down-slanting palpebral fissures and small lobules of both ears. At present, her developmental
abilities are still delayed for her chronological age but she is making evident progress with speech.
A postnatal array comparative genomic hybridization showed a 2.31 Mb genomic gain indicating microduplication derived
from pericentric regions q11.1 and q11.2 of chromosome 17. Additional conventional cytogenetic analysis from peripheral
blood characterized the karyotype as 47,XX,+mar in a non-mosaic form. The location of microduplication was confirmed
with fluorescence in situ hybridization.
Conclusion: The proband’s microduplication encompassed approximately 40 annotated genes, several of which have
been associated with phenotypic characteristics of the proband. This is the first report of sSMC 17 including this particular
chromosomal region in non-mosaic form.
Keywords: Small supernumerary marker chromosome, Developmental delay, Speech delay, Dysmorphic features,
fluorescence in situ hybridization
Background
Small supernumerary marker chromosomes (sSMC) are
a morphologically heterogeneous group of structurally
abnormal chromosomes that cannot be identified unam-
biguously by conventional cytogenetics. The definite
origin of sSMC can only be diagnosed using molecular
cytogenetic techniques [1]. sSMC frequency in newborns
is 0.04% [2] but their clinical variability may range from
normal to severely abnormal phenotype. The effects of
sSMC may be attributed to their size, presence of euchro-
matic material and degree of mosaicism [3]. Uniparental
disomy of sSMC’s sister chromosomes can also be identi-
fied [4]. The majority of sSMC cases arise de novo whilst
30% segregate within a family [3].
A de novo sSMC derived from a pericentric region of
the q arm in chromosome 17 in a centric minute shape
is described. It was identified postnatally and confirmed
with fluorescence in situ hybridization (FISH). To our
knowledge, this is the first report of this particular sSMC
17 in non-mosaic form.
Case presentation
The 4 years old proband was born after 36 weeks of gesta-
tion to non-consanguineous healthy parents. The pro-
band’s birth weight was 2600 g (10th-25th percentile),
birth length 47 cm (25th-50th percentile), occipital-frontal
circumference 32 cm (25th-50th percentile).
At the age of two months gastroesophageal reflux was
diagnosed. She walked unaided at 18 months and started
uttering her first words at the age of 3 years, when her
pediatrician referred her for further development assess-
ment. Her craniofacial features included round face,
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microstomia, small chin and down-slanting palpebral fis-
sures. Lobules of both ears were small. Ultrasound
examination of the heart and lung was unremarkable.
Metabolic, endocrine and biochemical screening results
were normal. Ophthalmologic examination showed
myopia and anisometropia. Neurologic examination re-
vealed mild general hypotonia with hypoplasia of orbicu-
lar oris muscle and levatorangulioris muscle. Her overall
speech skills were delayed for at least 1.5 years. Her
comprehension was limited to simple commands.
Speech therapist was involved for further speech
evaluation. She had a problem with concentration and
visual-motoric coordination. Psychological examination
revealed poor social interactions and severe hyperactiv-
ity. Other abnormal findings were supernumerary nipple
on the left side, proximal placement of the thumbs and
polycystic ovary. Dermatogliphes were normal; she had a
small hypopigmented skin lesion on right thigh.
From neonatal period to the present age she didn't have
significant health problems except recurrent otitis media.
At first she attended kindergarten for children with devel-
opmental problems, but recently joined a regular kindergar-
ten with additional speech and occupational therapy.
Once a year she is re-evaluated by the clinical geneticist.
Her developmental abilities are constantly improving but
are still delayed for her biological age. At the age of 4 she
uses limited number of words in few-word sentences and
understands simple commands. Her speech is sometimes
still unclear and problems with hyperactivity persist. At the
age of 4.2 years her developmental quotient (DQ) was calcu-
lated to be 0.68, representing significant development delay.
Molecular and cytogenetic analysis
All cytogenetics and molecular-genetics analyses were
performed with written and signed informed consent.
Cytogenetic studies were carried out on peripheral blood
lymphocytes from the patient and her parents. Cytogen-
etic analyses on metaphase-spread preparations were
performed with standard procedures using GTG banding
at a minimum 500 band resolution level according to
the International System for Human Cytogenetic
Nomenclature (ISCN 2013). Further molecular-
cytogenetics analyses were undertaken using the FISH
probe for chromosomal region 17q11.2 RP11-192H23
(BlueGnome, Illumina, San Diego, CA) on metaphase
and interphase chromosome spreads. Chromosomes
were counterstained with 4’,6-diamidino-2-phenylindole
(DAPI) and images were captured using the CytoVysion
Imaging System (Leica Biosystems. Wetzlar, DE).
Array comparative genomic hybridization (aCGH)
analysis was performed on genomic DNA from a pro-
band’s peripheral blood sample using a commercial
oligonucleotide array (Agilent 60 K ISCA Oligo, Agilent
Technologies, Santa Clara, CA) and sex-matched human
reference DNA sample (Agilent Technologies, Santa
Clara, CA). Data were analysed with the Cytogenomics
3.0 Software (Agilent Technologies, Santa Clara, CA).
Peripheral blood lymphocytes from both parents were
analysed by conventional karyotyping and additionally
using specific 17q11.2 FISH probe RP11-192H23 to ex-
clude the parental presence of sSMC or a balanced
chromosomal rearrangement.
Results
A postnatal aCGH showed a microduplication of 2.31 ±
0.06 Mb encompassing pericentric regions q11.1 and
q11.2 derived from chromosome 17 (arr[hg19]
17q11.1q11.2(25,403,446-27,716,930)x3) (Fig. 1). Based on
cytogenetic analysis of metaphases from peripheral blood
we interpreted the karyotype as 47,XX,+der(17)(:p11.1- >
q11.2:) in non-mosaic form. The location of microduplica-
tion was confirmed with molecular analysis using FISH
probe RP11-192H23 (Fig. 2). Based on its shape, size and
centromere we concluded that marker chromosome was a
centric minute sSMC 17. Parental analysis demonstrated
normal karyotypes and regular chromosomes 17 FISH
patterns, consistent with a de novo origin of sSMC.
Discussion
We found a de novo sSMC derived from chromosome re-
gion 17q11.1q11.2 using aCGH and FISH in a girl with de-
velopmental delay, speech delay, dysmorphic features and
hyperactivity. According to the sSMC 17 database at Jena
University Hospital, the proximal partial trisomy of q arm
of chromosome 17 in general leads to developmental
delay, dysmorphism, growth retardation, hypotonia, and
visual impairment [5]. All these characteristics were ob-
served in our proband. The duplicated region of cytoband
17q11.2 lies outside the potentially non dosage-sensitive
pericentric region as confirmed by molecular mapping
listed in sSMC database.
The formation of this de novo sSMC was probably due
to a partial trisomy rescue and may be the result of viable
postzygotic nondisjunction or anaphase lag event occur-
ring during early embryogenesis [3, 6]. Advanced maternal
age increases the incidence of meiotic non-disjunction
events [7] and in our case the mother was 33 years old at
the time of conception. There are numerous proposed
models for centric minute sSMC formation but so far no
pathways or enzymes involved in the processes of trisomy
rescue mechanisms were discovered [3]. Although the ma-
jority of this life saving outcomes result in mosaic sSMC
formation, the discrepancy in the level of mosaicism in
different tissues of the same individual is well established.
Trisomy rescue is also one of proposed mechanism for
uniparental disomy (UPD). It has been estimated that de
novo sSMC contribute to 4% of reported UPD cases [8].
However, UPD 17 is not regarded to be associated with
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any imprinting disorder. To date more than 3.300 cases
have been reported in UPD database, yet there are no re-
ports for coincidence of sSMC and mat/pat UPD 17 with
clinical finding. Therefore, we interpreted this minute cen-
tric de novo sSMC 17 as resulting from a combination of
meiosis non-disjunction event and incomplete trisomy
rescue event in which the majority of additional chromo-
some 17 was lost. The remaining minute sSMC 17 har-
bours genomic gain which is entirely causative for the
clinical phenotype.
The proband’s microduplication encompassed approxi-
mately 40 annotated OMIM genes, several of which
were reported as potentially associated with proband’s
phenotypic characteristics. Among clinically relevant
genes within the duplicated region were NOS2, TRAF4,
SEZ6, SARM1 and LGALS9. Gene NOS2 (OMIM
163730) encodes nitric oxidase synthase 2A that pro-
duces nitric oxide (NO), an important second messenger
molecule involved in the regulation of cardiovascular, im-
mune and neural system. NO has an array of functions in
Fig. 1 The result of aCGH indicating microduplication of chromosome 17 (arr[hg19]17q11.1q11.2(25,403,446-27,716,930)x3). Whole chromosome
17 and a close-up of duplicated region with annotated genes is visualized
Fig. 2 Results of high resolution G-banding (a) and FISH (b) with identified sSMC marked by arrows. The close-up of sSMC for corresponding metaphase is
presented in both smaller frames (c, d). The orange FISH signals are the result of metaphase hybridization with the probe RP11-192H23 (BlueGnome, Illumina)
Stavber et al. Molecular Cytogenetics  (2017) 10:10 Page 3 of 6
the central nervous system. In an association with cognitive
function it has an important role in the induction and
maintenance of synaptic plasticity [9]. Furthermore, the ex-
cess production of NO causes “nitrosative stress” and con-
sequent neurotoxicity. NO also acts at the level of
transcription and translation and regulates cell survival and
proliferation in diverse cell types, including neuron cells
[10]. So, it affects neurogenesis, where the continuous for-
mation and pruning of neuron synapses are the main pro-
cesses. Second gene TRAF4 (OMIM 602464) encodes TNF
receptor-associated factor 4, which is required during em-
bryogenesis for the formation of the trachea, the axial skel-
eton and the closure of neural tube. In addition, TRAF4
plays a role in proper myelination therefore its role in
ADHD, intellectual disability and movement disorder has
been previously suggested [11]. Other genes within the du-
plicated region were also of interest for possible genotype-
phenotype correlations. Gene SEZ6 (OMIM 616666) is
predicted to be involved in neuronal maturation and plasti-
city, based on animal studies [12]. Mary et al. reported that
SEZ6 expression correlates with the most active periods of
cortical neurogenesis and neuronal maturation [13]. Gene
SARM1 (OMIM 607732) activity is required after axon
injury to induce axon degeneration in mice [14], while
LGALS9 gene (OMIM 601879) encodes different lectins.
Specific interactions between carbohydrate moieties and
their putative binding proteins (i.e. lectins) play a critical
role in various developmental, physiologic, and pathologic
processes. Based on the description and the mechanism of
genes included in this sSMC, we suggest that duplication of
NOS2 and TRAF4 genes play a crucial role in our patient.
Altered NO production in brain may affect neurotoxicity
and eventually influence neurogenesis. It results in an in-
appropriate development and working of the whole central
nervous system, which could be a reason for the proband’s
developmental delay. It has been shown that TRAF4 is at-
tractive gene for movement disorders [11], so we can sug-
gest that duplication of TRAF4 is probably involved in our
patient’s hyperactivity. This observation remains speculative
and needs to be confirmed in other similar cases or func-
tional studies. Currently, there are no published reports for
SEZ6, SARM1 and LGALS9 involvement into development
of developmental delay or dysmorphism and their role in
the etiology of presented case is unclear. The comprehen-
sive study of all annotated genes in the duplicated region
was performed but no candidate genes for supernumerary
nipple or polycystic ovary was identified. However, the
function of many genes in the duplicated region is currently
not known.
To date, not a single reported case with the sSMC 17
encompassing this particular coordinates of pericentric
region of q11.1 and q11.2 was identical to ours. In
Table 1 we present overlapping cases from the literature.
The presence of sSMC 17 encompassing only the peri-
centric regions appears to be associated predominantly
with developmental delay and in some cases with
Table 1 Clinical cases of sSMC 17
Author Final result of sSMC 17 Clinical symptoms Ref.
Chen et al. 17q11.1q11.2 (25,372,965-27,725,134)
in mosaic form; prenatal diagnosis
ventricular septal defect, developmental delay, speech delay with
language problems at neonatal follows-up
[15]
Cornelius et al. 17p11.2q11.2 (21,200,000-27,500,000) in mosaic form 22-year-old male with Gilles de la Tourette syndrome, attention deficit
hyperactivity disorder (ADHD), intellectual disability and seizures
[11]
Vetro et al. sSMC(17) involving three duplications separated by two
single copy regions with a size of about 2.1 Mb and 615
kb (NCBI 36): 17p11.2 (16,892,427-19,888,467) (2,9 Mb),
17q11.1 (22,427,573-23,163,556) (319 kb) and 17q11.2
(23,848,894-25,676,268) (1,8 Mb)in mosaic form
severe global developmental delay, speech delay, hypotonia,
microcephaly and mild dysmorphic features
[16]
Kozma et al. r(17)(::p11.1→ q21::) in mosaic form; no
coordinates given
38-year-old male with developmental delay, profound mental
retardation, kyphoscoliosis, bilateral cataracts, severe calcaneovalgus
deformity of the feet, dysmorphic facies, mitral valve prolapse with
regurgitation and severe respiratory insufficiency. He never
developed any speech.
[17]
Capovia P. et al. min(17)(:p11.1/q11.2:) in size of 10 Mb; in mosaic form 2-year-old male with minor facial dysmorphic features,
developmental delay (especially speech delay), short stature and
Potocki-Lupski syndrome
[18]
Jason Anderson min (17) (23,086,100-32,754,790 MB) developmental delay in newborn [5]
Manolakos et al. min(17) of three duplications: (p11.2→ p11.2; 16.9-19.89)
(p11.1→ q11.1; 22.42-23.16) (q11.2→ q11.2; 23.84-25.67)
in non-mosaic form
significantly delayed developmental milestones (sitting unsupported
at 12 months, walking unaided at 22 months, started uttering first
words at 2.5 years), mild dysmorphic facial and body features
(microcephaly, narrow palpebral fissures, small eyes, high-arched
palate, low set ears, short hands and fingers and clinodactyly of the
5th finger), severe hypotonia, microcephaly, IQ <46 (at 17 months)
[19]
Neill NJ et al. mar(17) (:p11.1→ q11.2:) in mosaic form abnormal [20]
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intellectual disability, meanwhile patients with sSMC 17
of larger parts of either the short or the long arm of
chromosome 17 have additional dysmorphic features
[11]. The duplicated genomic region of the present case
is the most comparable to that of Chen et al.[15],
although our proband’s heart examination did not reveal
any abnormalities. Both cases manifested with develop-
mental delay and speech delay, despite the fact that
sSMC 17 in the Chen et al. case was in a mosaic form.
Cornelius et al. described another similar case [11] and
suggested that the duplication of NOS2 plays a role in
the ADHD symptoms of their patient. Cornelius et al.
also suggested that the duplication of TRAF4 plays a role
in ADHD, intellectual disability and movement disorder.
Although the present proband does not fulfill all the cri-
teria of ADHD, she has a severe form of hyperactivity.
Conclusion
We report a de novo sSMC derived from 17q11.1q11.2
in association with developmental delay, speech delay
and mild dysmorphism. This unique clinical case was
compared to published overlapping cases. We conclude
that the identification of the origin, the size and the
composition of sSMC using aCGH and FISH are essen-
tial for precise genotype-phenotype correlation. Further-
more, thorough molecular-cytogenetic characterization
of sSMC is needed for the prediction of clinical progno-
sis and genetic counseling.
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